Salicylic acid

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for adults is 500 mg administered orally every 12 hours. For pediatric patients aged 6 to 12 years, the dosage is 250 mg taken orally every 12 hours.

It is important to note that the maximum daily dosage should not exceed 2000 mg. All doses should be taken at regular intervals, specifically every 12 hours, to maintain optimal therapeutic levels.

Contraindications

Use is contraindicated in the following situations:

Patients should not use this product if discomfort persists, as continued use may exacerbate underlying conditions. Additionally, individuals with diabetes or poor blood circulation should avoid this product due to potential complications associated with these conditions. It is also contraindicated to swallow the product; in the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately.

Warnings and Precautions

For external use only, this product must be applied solely to the affected area. It is imperative to keep the product away from fire and flame to prevent any hazardous incidents.

General precautions should be observed to ensure safe usage. Users must avoid contact with the eyes; in the event of exposure, it is essential to flush the eye with water for at least 15 minutes. Inhalation of vapors should also be avoided to minimize respiratory irritation. The bottle should be capped tightly after each use to maintain product integrity. Additionally, the product should be stored out of direct sunlight and at room temperature, away from heat sources.

Patients are advised to discontinue use and consult a healthcare professional if discomfort persists. Special caution is warranted for individuals with diabetes or poor blood circulation, as they may be at increased risk for adverse effects. In cases of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Emergency medical help should be obtained without delay if the product is swallowed. Prompt action is crucial in such situations to ensure patient safety.

Side Effects

Patients should be aware that the product is for external use only and must be applied solely to the affected area. It is crucial to keep the product away from fire and flame to prevent any potential hazards.

In the event that discomfort persists after application, patients are advised to discontinue use and consult a healthcare professional. Special caution is warranted for individuals with diabetes or poor blood circulation, as these conditions may increase the risk of adverse effects.

Additionally, the product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Bee Venom Wart Remover Liquid. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The product has not been evaluated for safety in pregnancy, and caution is advised as the safety of the active ingredients during this period is not established. There is no specific information available regarding risks to the fetus. Additionally, no dosage modifications are provided for pregnant individuals, and no special precautions are mentioned regarding use during pregnancy. Healthcare professionals should consider these factors when prescribing this product to pregnant patients or women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, altered mental status, cardiovascular instability, or gastrointestinal disturbances.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. Healthcare professionals should also consider contacting a poison control center for additional guidance on the management of overdose cases.

In summary, while specific overdosage information is not available, prompt recognition and appropriate management of overdose symptoms are critical in ensuring patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion or misuse.

When using this product, patients should be instructed to avoid contact with the eyes. In the event that the product does come into contact with the eyes, they should flush the eyes with water for at least 15 minutes. Additionally, patients should be cautioned against inhaling vapors from the product. It is important for patients to ensure that the bottle is capped tightly after use and to store the product out of direct sunlight, at room temperature, and away from heat sources.

Patients should be informed to stop using the product and consult a doctor if discomfort persists. Special attention should be given to patients with diabetes or poor blood circulation, as they may be at increased risk. In case of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately.

Storage and Handling

The product is supplied in a container that must be capped tightly to maintain its integrity. It should be stored at room temperature, ensuring it is kept away from heat sources. Additionally, it is important to protect the product from direct sunlight to preserve its quality.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Bee Venom Wart Remover Liquid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)